TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

ROGAINE EXTRA STRENGTH (FOR MEN)

MINOXIDIL
Approved 1997-11-14
Jump to: Indications Approvals Trials Competitors Safety Patents
1
Indication
--
Phase 3 Trials
28
Years on Market

Details

Status
Over-the-counter
First Approved
1997-11-14
Routes
TOPICAL
Dosage Forms
SOLUTION

Companies

KENVUE BRANDS
Active Ingredient: MINOXIDIL

ROGAINE EXTRA STRENGTH (FOR MEN) Approval History

Loading approval history...

What ROGAINE EXTRA STRENGTH (FOR MEN) Treats

1 FDA approvals

Originally approved for its first indication in 1997 .

  • Other (1)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ROGAINE EXTRA STRENGTH (FOR MEN) FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA020834 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.